Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-14 5:40 PM View:  | Ahrens Brenton Karl Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition (change in control) Duplicate | 1,902,030 | -- | -- | (100%) 1.9M to 0 | |
| 19-Nov-14 5:44 PM View: | Canaan Viii Lp Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition (change in control) | 1,902,030 | -- | -- | (100%) 1.9M to 0 | |
| 18-Nov-14 12:06 PM View: | Domain Associates 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 6,250 | -- | -- | (100%) 6.25K to 0 | |
| 19-Nov-14 12:17 PM View: | Giles Lisa M. Director | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 2,500 | -- | -- | (100%) 2.5K to 0 | |
| 19-Nov-14 5:40 PM View: | Ahrens Brenton Karl Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 5,034 | -- | -- | (< 1%) 1.91M to 1.9M | |
| 19-Nov-14 5:44 PM View: | Canaan Viii Lp Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition Duplicate | 5,034 | -- | -- | (< 1%) 1.91M to 1.9M | |
| 18-Nov-14 6:51 PM View: | Fishman Corey N. CFO&COO | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 24,941 | -- | -- | (100%) 24.94K to 0 | |
| 19-Nov-14 7:19 AM View: | de Schutter Richard U Director | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 15,000 | -- | -- | (55%) 27.5K to 12.5K | |
| 18-Nov-14 6:32 PM View: | Shannon John Patrick Jr Chief Commercial Officer | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 11,000 | -- | -- | (100%) 11.0K to 0 | |
| 18-Nov-14 12:16 PM View: | Domain Partners Viii, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 3,006,130 | -- | -- | (100%) 3.01M to 0 | |
| 19-Nov-14 7:19 AM View: | de Schutter Richard U Director | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 12,500 | -- | -- | (100%) 12.5K to 0 | |
| 18-Nov-14 6:29 PM View: | Edick Paul R Chief Executive Officer Director | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 46,136 | -- | -- | (100%) 46.14K to 0 | |
| 18-Nov-14 12:11 PM View: | Dp Viii Associates, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 22,306 | -- | -- | (100%) 22.31K to 0 | |
| 18-Nov-14 6:52 PM View: | Oboyle Kevin C Director | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 18-Nov-14 6:28 PM View: | Dunne Michael W. Chief Medical Officer | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 13,220 | -- | -- | (100%) 13.22K to 0 | |
| 18-Nov-14 4:10 PM View: | New Leaf Ventures Ii, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 17-Nov-14 | Disposition | 3,028,440 | -- | -- | (100%) 3.03M to 0 | |
| 19-Nov-14 5:30 PM View: | Ahrens Brenton Karl Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 26-Aug-14 | Option Exercise | 5,034 | $2.08 | $10,470.70 | < 1% 1.9M to 1.91M | |
| 19-Nov-14 5:33 PM View: | Canaan Viii Lp Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 26-Aug-14 | Option Exercise Duplicate | 5,034 | $2.08 | $10,470.70 | < 1% 1.9M to 1.91M | |
| 13-Aug-14 5:13 PM View: | Shannon John Patrick Jr Chief Commercial Officer | Durata Therapeutics, Inc. (DRTX) | 12-Aug-14 | Market Purchase | 3,000 | $13.72 | $41,160.00 | 38% 8.0K to 11.0K | 75% |
| 13-Jun-14 1:53 PM View: | Edick Paul R Chief Executive Officer Director | Durata Therapeutics, Inc. (DRTX) | 12-Jun-14 | Market Purchase | 3,000 | $15.23 | $45,690.00 | 7% 43.14K to 46.14K | 58% |
| 22-May-14 4:20 PM View: | Aisling Capital III Lp 10% Owner | Durata Therapeutics, Inc. (DRTX) | 20-May-14 | Disposition (other) | 749,258 | -- | -- | (25%) 3.04M to 2.29M | |
| 14-May-14 5:53 PM View: | de Schutter Richard U Director | Durata Therapeutics, Inc. (DRTX) | 12-May-14 | Market Purchase | 15,000 | $15.57 | $233,505.00 | 120% 12.5K to 27.5K | 54% |
| 21-Mar-14 8:08 PM View: | Aisling Capital III Lp 10% Owner | Durata Therapeutics, Inc. (DRTX) | 21-Mar-14 | Market Sale | 2,649 | $15.57 | $41,255.00 | (< 1%) 3.03M to 3.03M | (54%) |
| 21-Mar-14 8:08 PM View: | Aisling Capital III Lp 10% Owner | Durata Therapeutics, Inc. (DRTX) | 20-Mar-14 | Market Sale | 98,000 | $15.74 | $1,542,590.00 | (3%) 3.13M to 3.03M | (53%) |
| 03-Dec-13 4:58 PM View: | Giles Lisa M. Director | Durata Therapeutics, Inc. (DRTX) | 03-Dec-13 | Market Purchase | 1,000 | $10.95 | $10,950.00 | 100% 0 to 1.0K | 119% |
| 20-May-13 1:36 PM View: | Edick Paul R Chief Executive Officer Director | Durata Therapeutics, Inc. (DRTX) | 20-May-13 | Market Purchase | 3,000 | $7.09 | $21,267.00 | 7% 40.14K to 43.14K | 239% |
| 16-Aug-12 3:03 PM View: | Edick Paul R Chief Executive Officer Director | Durata Therapeutics, Inc. (DRTX) | 14-Aug-12 | Market Purchase | 5,000 | $8.65 | $43,250.00 | 25% 19.64K to 24.64K | 178% |
| 23-Jan-14 12:52 PM View: | Giles Lisa M. Director | Durata Therapeutics, Inc. (DRTX) | 06-Aug-12 | Market Purchase | 500 | $8.25 | $4,125.00 | 50% 1.0K to 1.5K | 188% |
| 26-Jul-12 7:42 PM View: | Ahrens Brenton Karl Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 555,555 | $9.00 | $5,000,000.00 | 41% 1.35M to 1.9M | |
| 24-Jul-12 12:10 PM View: | Domain Partners Viii, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 778,536 | $9.00 | $7,006,820.00 | 35% 2.23M to 3.01M | |
| 24-Jul-12 12:13 PM View: | Halak Brian K 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,244,120 | -- | -- | 100% 0 to 2.24M | |
| 26-Jul-12 6:25 PM View: | Hunt Ronald Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,244,130 | -- | -- | 100% 0 to 2.24M | |
| 24-Jul-12 12:04 PM View: | Vitullo Nicole Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 25-Jul-12 3:31 PM View: | Healy James Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 588,236 | $9.00 | $5,294,120.00 | 17% 3.37M to 3.96M | |
| 24-Jul-12 12:01 PM View: | Treu Jesse I 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,244,120 | -- | -- | 100% 0 to 2.24M | |
| 24-Jul-12 12:16 PM View: | Blair James C 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 14-Feb-13 5:54 PM View: | Fishman Corey N. CFO & COO | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 2,500 | $9.00 | $22,500.00 | 11% 22.44K to 24.94K | |
| 24-Jul-12 12:07 PM View: | Dp Viii Associates, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 5,777 | $9.00 | $51,993.00 | 35% 16.53K to 22.31K | |
| 14-Feb-13 5:51 PM View: | Dunne Michael W. Chief Medical Officer | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 2,000 | $9.00 | $18,000.00 | 18% 11.22K to 13.22K | |
| 26-Jul-12 5:50 PM View: | New Leaf Ventures Ii, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 25-Jul-12 5:08 PM View: | Aisling Capital III Lp 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase | 1,111,110 | $9.00 | $10,000,000.00 | 55% 2.02M to 3.13M | |
| 24-Jul-12 12:10 PM View: | Domain Partners Viii, L.P. 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion | 2,227,600 | -- | -- | 100% 0 to 2.23M | |
| 25-Jul-12 5:11 PM View: | Goldstein Dov A Md Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,019,710 | -- | -- | 100% 0 to 2.02M | |
| 26-Jul-12 7:59 PM View: | Canaan Viii Lp Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion | 1,346,480 | -- | -- | 100% 0 to 1.35M | |
| 24-Jul-12 12:13 PM View: | Halak Brian K 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 26-Jul-12 6:25 PM View: | Hunt Ronald Director 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 24-Jul-12 11:58 AM View: | Schoemaker Kathleen K 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion Duplicate | 2,244,120 | -- | -- | 100% 0 to 2.24M | |
| 24-Jul-12 12:01 PM View: | Treu Jesse I 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Purchase Duplicate | 784,313 | $9.00 | $7,058,820.00 | 35% 2.24M to 3.03M | |
| 24-Jul-12 11:57 AM View: | Dovey Brian H 10% Owner | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion | 2,244,120 | -- | -- | 100% 0 to 2.24M | |
| 26-Jul-12 5:54 PM View: | Edick Paul R Chief Executive Officer Director | Durata Therapeutics, Inc. (DRTX) | 24-Jul-12 | Conversion | 19,636 | -- | -- | 100% 0 to 19.64K |
